Charles Schwab Investment Management »

Bioxcel Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $553k 188k 2.95
2023-09-30 $346k 137k 2.53
2023-06-30 $987k 148k 6.66
2023-03-31 $2.7M 144k 18.66
2022-12-31 $3.1M 143k 21.48
2022-09-30 $1.7M 141k 11.82
2022-06-30 $1.7M 125k 13.20
2022-03-31 $2.8M 135k 20.91
2021-12-31 $2.7M 132k 20.33
2021-09-30 $3.9M 130k 30.35
2021-06-30 $3.0M 103k 29.06
2021-03-31 $4.1M 96k 43.17
2020-12-31 $4.3M 94k 46.21
2020-09-30 $3.9M 91k 43.37
2020-06-30 $1.4M 26k 53.02
2020-03-31 $341k 15k 22.39
2019-12-31 $221k 15k 14.64
2019-09-30 $89k 13k 7.10
2019-06-30 $138k 13k 11.01